Sichuan Innovation CDMO Platform Recognized as a High-Tech Enterprise

In December 2025, the CDMO platform of Sichuan Innovation was officially recognized as a national “High-Tech Enterprise.” The nature of medical devices imposes significant technical barriers and compliance challenges. As the first Class III medical device CDMO platform in Western China to meet both U.S. FDA and China GMP regulations, this successful certification as a “High-Tech Enterprise” marks a major milestone for Lujian Technology and Sichuan Innovation. It signifies their breakthrough in the industrialization of high-end medical devices and fills the gap in compliant production for complex Class III devices in the region. Lujian Technology will further strengthen its cooperation with both domestic and international innovative enterprises and regulatory bodies.